Abstract
The invention provides a method of determining the epigenetic chromosome interactions which are relevant to a prognostic companion epigenetic test for cancer.
Full Text
What is claimed is:
The invention provides a method of determining the epigenetic chromosome interactions which are relevant to a prognostic companion epigenetic test for cancer.
Timeline
Filed
05/04/2026Published
08/27/2026Granted
Not AvailableIPC Codes(2)
C12Q 1/6886:for cancer (immunoassay for cancer G01N 33/575)
C12Q 1/6827:for detection of mutation or polymorphism